Latest Insider Transactions at T Scan Therapeutics, Inc. (TCRX)
This section provides a real-time view of insider transactions for T Scan Therapeutics, Inc. (TCRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of TScan Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of TScan Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 23
2024
|
Barbara Klencke |
BUY
Open market or private purchase
|
Direct |
5,000
+10.0%
|
$25,000
$5.29 P/Share
|
|
Aug 26
2024
|
Barbara Klencke |
BUY
Open market or private purchase
|
Direct |
5,000
+11.11%
|
$25,000
$5.53 P/Share
|
|
Aug 23
2024
|
Barbara Klencke |
BUY
Open market or private purchase
|
Direct |
5,000
+12.5%
|
$25,000
$5.69 P/Share
|
|
Aug 23
2024
|
Zoran Zdraveski |
SELL
Open market or private sale
|
Direct |
164,686
-97.22%
|
$823,430
$5.78 P/Share
|
|
Aug 23
2024
|
Zoran Zdraveski |
BUY
Exercise of conversion of derivative security
|
Direct |
157,186
+26.23%
|
$471,558
$3.11 P/Share
|
|
Dec 19
2023
|
Timothy J Barberich |
BUY
Open market or private purchase
|
Direct |
317
+0.47%
|
$1,268
$4.97 P/Share
|
|
Dec 18
2023
|
Timothy J Barberich |
BUY
Open market or private purchase
|
Direct |
28,830
+30.18%
|
$115,320
$4.89 P/Share
|
|
Dec 14
2023
|
Barbara Klencke |
BUY
Open market or private purchase
|
Direct |
5,000
+14.29%
|
$25,000
$5.08 P/Share
|
|
Jun 02
2023
|
Timothy J Barberich |
BUY
Open market or private purchase
|
Direct |
37,880
+50.0%
|
$75,760
$2.63 P/Share
|
|
May 31
2023
|
Lynx1 Capital Management LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
15,400
-0.15%
|
$30,800
$2.52 P/Share
|
|
May 31
2023
|
Lynx1 Capital Management LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,000
-0.19%
|
$20,000
$2.51 P/Share
|
|
Dec 28
2022
|
Brian M. Silver Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
3,158
+8.76%
|
$3,158
$1.56 P/Share
|
|
Dec 27
2022
|
Brian M. Silver Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,842
+8.73%
|
$2,842
$1.5 P/Share
|
|
May 18
2022
|
David P Southwell Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
25,000
+7.0%
|
$75,000
$3.59 P/Share
|
|
May 11
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
25,865
+1.01%
|
$25,865
$1.99 P/Share
|
|
May 10
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
1,333,927
+16.98%
|
$1,333,927
$1.86 P/Share
|
|
Mar 24
2022
|
Brian M. Silver Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+35.81%
|
$45,000
$3.4 P/Share
|
|
Dec 23
2021
|
David P Southwell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
48,670
+24.93%
|
$48,670
$1.97 P/Share
|
|
Sep 23
2021
|
Zoran Zdraveski |
BUY
Open market or private purchase
|
Direct |
4,716
+50.0%
|
$33,012
$7.48 P/Share
|
|
Sep 21
2021
|
Brian M. Silver Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+29.61%
|
$30,000
$6.32 P/Share
|
|
Sep 21
2021
|
Gavin Mac Beath Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
57
+0.11%
|
$342
$6.19 P/Share
|
|
Sep 20
2021
|
Gavin Mac Beath Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,943
+9.04%
|
$29,658
$6.22 P/Share
|
|
Sep 09
2021
|
Brian M. Silver Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,885
+46.08%
|
$47,080
$8.48 P/Share
|
|
Sep 08
2021
|
David P Southwell Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
11,000
+10.1%
|
$88,000
$8.73 P/Share
|
|
Aug 27
2021
|
William Desmarais Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+50.0%
|
$22,500
$9.08 P/Share
|
|
Jul 20
2021
|
Timothy J Barberich |
BUY
Conversion of derivative security
|
Direct |
33,259
+50.0%
|
-
|
|
Jul 20
2021
|
Christoph H Westphal > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
133,333
+9.44%
|
$1,999,995
$15.0 P/Share
|
|
Jul 20
2021
|
Christoph H Westphal > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,145,505
+50.0%
|
-
|
|
Jul 20
2021
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
1,425,000
+50.0%
|
$21,375,000
$15.0 P/Share
|
|
Jul 20
2021
|
Brian M. Silver Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$15,000
$15.0 P/Share
|